Loading insider details...
Beta
Latest Form 4 (Mar 2, 2026): Sale of 8,541 OVID shares, $12.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 2, 2026 | Ovid Therapeutics Inc. (OVID) | Sale | 8,541 | $12.4K |
| Feb 28, 2025 | Ovid Therapeutics Inc. (OVID) | Sale | 3,902 | $2.2K |
| Feb 25, 2025 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 43,750 | n/a |
| Dec 19, 2024 | S&W Seed Co (SANW) | Grant/Award | 12,725 | n/a |
| Aug 1, 2024 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 315,000 | n/a |
| Feb 26, 2024 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 28,125 | n/a |
| Dec 19, 2023 | S&W Seed Co (SANW) | Grant/Award | 151,525 | n/a |
| Feb 27, 2023 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 175,000 | n/a |
| Apr 12, 2022 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 194,399 | n/a |
| Feb 4, 2022 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 218,750 | n/a |